Abscopal Effect Following Radiation Therapy in Cancer Patients: A New Look from the Immunological Point of View
محل انتشار: مجله فیزیک و مهندسی پزشکی، دوره: 10، شماره: 4
سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 52
فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JBPE-10-4_015
تاریخ نمایه سازی: 30 دی 1402
چکیده مقاله:
Abscopal effect, a radiobiology term meaning “away from target”, was practically unheard of just ten years ago. This effect describes the elimination and cure of a non-treated tumor when another part of the body is irradiated. Successful treatment of cancer in patients with multiple metastatic foci has sporadically been reported. Abscopal effect after radiotherapy has been introduced as the key factor which induced an anticancer response in these metastatic lesions. Moreover, not receiving chemotherapy is reported to have a role in cancer regression after radiotherapy. Given this consideration, it can be hypothesized that standard radiotherapy doses, which usually classified as high-dose, may cause cancer cells to expose or release their sequestered antigens that had been previously masked. Furthermore, radiotherapy can decrease the suppressive effect of regulatory T cells which usually down modulate immune responses against cancers. Moreover, some data show that low dose total-body irradiation (TBI) alone (without standard localized high dose radiotherapy) may cause suppression of distant metastasis of tumor cells. Induction of a “whole body abscopal effect” can be involved in suppression of distant metastasis. Here we discuss whether cancer treatments could be more successful if immune system is boosted, not destroyed by the treatments such as chemotherapy.
کلیدواژه ها:
نویسندگان
J Welsh
MD, PhD, Department of Radiation Oncology, Edward Hines Jr VA Hospital, Hines, IL ۶۰۱۴۱, United States
J J Bevelacqua
PhD, Bevelacqua Resources, Richland, Washington ۹۹۳۵۲, United States
L Dobrzyński
PhD, National Centre for Nuclear Research, Otwock-Świerk, Poland
S A R Mortazavi
MD, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Sh Farjadian
PhD, Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
S M J Mortazavi
PhD, Department of Medical Physics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :